M&A Deal Summary

Advent International and LANXESS Acquire DSM Engineering Materials

On May 31, 2022, private equity firm Advent International and LANXESS acquired manufacturer DSM Engineering Materials from Koninklijke DSM for 3.7B EUR

Acquisition Highlights
  • This is Advent International’s 5th and LANXESS’s 1st transaction in the Manufacturing sector.
  • This is Advent International’s 6th and LANXESS’s largest (disclosed) transaction.
  • This is Advent International’s 9th and LANXESS’s 3rd transaction in the Netherlands.

M&A Deal Summary

Date 2022-05-31
Target DSM Engineering Materials
Sector Manufacturing
Buyer(s) Advent International
LANXESS
Sellers(s) Koninklijke DSM
Deal Type Divestiture
Deal Value 3.7B EUR

Target

DSM Engineering Materials

Heerlen, Netherlands
DSM Engineering Materials provides high-performance and increasingly sustainable thermoplastics used in automotive, electrical & electronics, building & construction, medical, food packaging, and consumer goods (to name but a few). Its materials enable lighter, stronger, and more durable products - which in turn makes people’s lives safer, more convenient, and healthier – and all while helping to tackle carbon emissions.

Search 196,055 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

Advent International

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1984
PE ASSETS 76.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.


DEAL STATS #
Overall 319 of 331
Sector (Manufacturing) 5 of 5
Type (Divestiture) 36 of 37
Country (Netherlands) 9 of 9
Year (2022) 9 of 12
Size (of disclosed) 6 of 47
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-17 SOMAR

Benito Juarez , Mexico

SOMAR is a pharmaceutical company focused on the development, manufacture, and marketing of high-quality generic and branded generic products in Mexico. SOMAR focuses on a number of key primary care market segments including dermatology medications. SOMAR is based in Benito Juarez, Mexico.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-01 NielsenIQ

Chicago, Illinois, United States

NielsenIQ is a comprehensive data, analytics, and insights company for global retailers and brands. NielsenIQ delivers the complete truth to retailers, manufacturers, and partners through comprehensive data sets and powerful insights. NielsenIQ was founded in 2020 and is based in Chicago, Illinois.

Sell -
Buyer

LANXESS

Cologne, Germany

website


Category Company
Founded 1863
Sector Chemicals
Employees12,621
Revenue 6.7B EUR (2023)
DESCRIPTION
Entrance to Lanxess' Pittsburgh, Pennsylvania office.
Entrance to Lanxess' Pittsburgh, Pennsylvania office.

LANXESS is a specialty chemicals company. The company is currently represented at 52 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of plastics, rubber, intermediates, and specialty chemicals. LAXNESS was founded in 1863 and is based in Cologne, Germany.


DEAL STATS #
Overall 16 of 16
Sector (Manufacturing) 1 of 1
Type (Divestiture) 6 of 6
Country (Netherlands) 3 of 3
Year (2022) 1 of 1
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-23 International Flavors & Fragrances - Microbial Control Business

New York, New York, United States

IFF’s Microbial Control business unit is a global leader that provides innovative and sustainable solutions. The business unit specializes in offering preservation and hygiene solutions for a wide array of industrial and consumer applications, including paints & coatings, building materials, animal biosecurity, personal care, and home care.

Buy $1.3B

Seller(S) 1

SELLER

Koninklijke DSM

Heerlen, Netherlands

website


Category Company
Founded 1902
Sector Life Science
Employees21,760
Revenue 9.2B EUR (2021)
DESCRIPTION

Koninklijke DSM specializes in the development, manufacture and marketing of performance materials, nutritional and pharmaceutical ingredients and industrial chemicals. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. Koninklijke DSM founded in 1902 and is based in Heerlen, the Netherlands.


DEAL STATS #
Overall 16 of 16
Sector (Manufacturing) 1 of 1
Type (Divestiture) 15 of 15
Country (Netherlands) 10 of 10
Year (2022) 2 of 2
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-20 DSM - Protective Materials Business

Heerlen, Netherlands

DSM's Protective Materials Business provides the development of ultra-strong bio-based and circular materials.

Sell €1.4B